TMBIM6, known as BAX inhibitor 1 27, functions as an anti-apoptotic factor and is notably upregulated in various diseases, including breast cancer 44, laryngeal squamous cell carcinoma 45, and glioblastoma multiforme 46. Here, TMBIM6 is linked to laryngeal squamous cell carcinoma.